Literature DB >> 4968792

A case of tetramer Bence Jones proteinaemia.

H M Grey, P F Kohler.   

Abstract

Mesh：

Substances：

Year:  1968        PMID： 4968792      PMCID： PMC1578884     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  13 in total

1.  BENCE JONES PROTEINEMIA.

Authors:  A SOLOMON; J L FAHEY
Journal:  Am J Med       Date:  1964-08       Impact factor: 4.965

2.  DISULPHIDE BRIDGES AND DIMERS OF BENCE-JONES PROTEIN.

Authors:  C MILSTEIN
Journal:  J Mol Biol       Date:  1964-09       Impact factor: 5.469

3.  MONOMER--DIMER FORMS OF BENCE JONES PROTEINS.

Authors:  G M BERNIER; F W PUTNAM
Journal:  Nature       Date:  1963-10-19       Impact factor: 49.962

4.  Starch-gel immunoelectrophoresis.

Authors:  M D POULIK
Journal:  J Immunol       Date:  1959-06       Impact factor: 5.422

5.  Passage of molecules through capillary wals.

Authors:  J R PAPPENHEIMER
Journal:  Physiol Rev       Date:  1953-07       Impact factor: 37.312

6.  TWO TYPES OF gamma-MYELOMA PROTEINS, beta(2A)-MYELOMA PROTEINS, gamma(1)-MACROGLOBULINS, AND BENCE JONES PROTEINS IDENTIFIED BY TWO GROUPS OF COMMON ANTIGENIC DETERMINANTS.

Authors:  J L Fahey; A Solomon
Journal:  J Clin Invest       Date:  1963-06       Impact factor: 14.808

7.  Zone electrophoresis.

Authors:  H G KUNKEL
Journal:  Methods Biochem Anal       Date:  1954

8.  Renal clearances of dextrans of varying molecular weights.

Authors:  D B BREWER
Journal:  Proc R Soc Med       Date:  1951-07

9.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

10.  Multiple-myeloma proteins. III. The antigenic relationship of Bence Jones proteins to normal gammaglobulin and multiple-myeloma serum proteins.

Authors:  L KORNGOLD; R LIPARI
Journal:  Cancer       Date:  1956 Mar-Apr       Impact factor: 6.860
View more
  5 in total

1.  Heterogeneity in primary structure, post-translational modifications, and germline gene usage of nine full-length amyloidogenic kappa1 immunoglobulin light chains.

Authors:  Lawreen H Connors; Yan Jiang; Marianna Budnik; Roger Théberge; Tatiana Prokaeva; Kip L Bodi; David C Seldin; Catherine E Costello; Martha Skinner
Journal:  Biochemistry       Date:  2007-11-16       Impact factor: 3.162

2.  A half-molecule GK plasmacytoma.

Authors:  J R Hobbs; A Jacobs
Journal:  Clin Exp Immunol       Date:  1969-07       Impact factor: 4.330

3.  Monoclonal proteinuria predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100.

Authors:  Alissa Visram; S Vincent Rajkumar; Prashant Kapoor; Angela Dispenzieri; Martha Q Lacy; Morie A Gertz; Francis K Buadi; Suzanne R Hayman; David Dingli; Taxiarchis Kourelis; Wilson Gonsalves; Rahma Warsame; Eli Muchtar; Nelson Leung; Robert A Kyle; Shaji K Kumar
Journal:  Leukemia       Date:  2022-02-21       Impact factor: 12.883

4.  Immunoglobulins in Jamaicans and Nigerians with immunogenetic typing of myeloma and lymphoma in Jamaicans.

Authors:  H McFarlane; A Talerman; A G Steinberg
Journal:  J Clin Pathol       Date:  1970-03       Impact factor: 3.411

5.  Pathogenic potential of human monoclonal immunoglobulin light chains: relationship of in vitro aggregation to in vivo organ deposition.

Authors:  E A Myatt; F A Westholm; D T Weiss; A Solomon; M Schiffer; F J Stevens
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.